ePostersLive by SCIGEN TECHNOLOGIES
434 posters, 
31 sessions, 
2382 authors, 
1064 institutions

Vaccines and prevention

Posters
  1. 1022
    IMMUNOLOGICAL HYPORESPONSIVENESS TO PNEUMOCOCCAL CONJUGATE VACCINES (PCV) ASSOCIATED WITH REPEATED USE OF PPV23 IN ASPLENIC β-THALASSEMICS: A 7-YEAR FOLLOW-UP
    I. Papadatou
    K. Alexandraki
    G. Orthopoulos
    A. Kattamis
    M. Theodoridou
    V. Spoulou
    Aghia Sophia Children's Hospital, University of Athens Department of Infectious Diseases
    University of Athens Endocrine Division, Department of Pathophysiology
    Aghia Sophia Children's Hospital, University of Athens Thalassemia Unit
  2. 1036
    10 YEARS OF A SINGLE DOSE MENINGOCOCCAL C VACCINATION PROGRAMME IN FLANDERS: PERSISTENT HERD IMMUNITY WITHOUT ANY VACCINE FAILURES
    G. Top
    A. Paeps
    Public Health Surveillance of Flanders Control of Infectious Diseases and Vaccinations
  3. 1038
    DIFFERENCES OF IGG-ANTIBODY-AVIDITY AFTER AN ACELLULAR PERTUSSIS-AP BOOSTER IN ADOLESCENTS WITH A PREVIOUS WHOLE CELL-WCP OR AP PRIMARY VACCINATION
    M. Prelog
    G. Almanzar
    N. Rieber
    M. Zlamy
    C.H. Wirsing von König
    J. Liese
    University of Wuerzburg Department of Pediatrics
    University of Tuebingen Department of Pediatrics
    Medical University Innsbruck Department of Pediatrics
    Institute for Hygiene and Laboratory Medicine, Helios Klinikum
  4. 1054
    PECULIARITIES OF SUBSTRAIN BCG RUSSIA 368
    O. Voronina
    M. Kunda
    E. Aksenova
    V. Lunin
    A. Gintsburg
    N.F. Gamaleya Institute for Epidemiology and Microbiology
  5. 1094
    UNIVERSAL HEPATITIS B VACCINATION IN BELGIUM: REPERCUSSION ON SEROLOGY IN UP TO 19 YEAR-OLDS AT TWO DIFFERENT TIMEPOINTS
    H. Theeten
    V. Hutse
    K. Hoppenbrouwers
    P. Beutels
    P. Van Damme
    University of Antwerp Vaccine and Infectious Disease Institute
    Institute of Public Health Virology Department
    KU Leuven Youth Health Care Department
  6. 1156
    WHO CAUSES PERTUSSIS DISEASE IN THE YOUNGEST INFANTS?
    L. Nilsson
    A.-M. Kling
    M. Grünewald
    K. von Segebaden
    T. Lepp
    Swedish Institute for Communicable Disease Control Diagnostics and Vaccinology
  7. 1160
    IMPROVING SECURITY AND ADHERENCE TO IMMUNIZATION
    H. Giamberardino
    A. Hoinski
    Hospital Pequeno Principe
  8. 1163
    IMMUNOPROPHYLAXIS FOR RESPIRATORY SYNCITIAL VIRUS BRONCHIOLITIS AMONG INFANTS WITH SEVERE OSTEOGENESIS IMPERFECTA: NEW INDICATION AND NATIONAL AUDIT IN IRELAND
    R. Philip
    S. Qadri
    University Hospital Limerick Paediatrics
  9. 117
    FOUR YEARS PNEUMOCOCCAL CONJUGATE INFANT VACCINATION IN GERMANY: IMPACT ON INCIDENCE OF INVASIVE INFECTIONS AND SEROTYPE DISTRIBUTION IN CHILDREN
    S. Weiß
    M. van der Linden
    G. Falkenhorst
    K. Schönberger
    R. von Kries
    Ludwig-Maximilians-University Institute for Social Paediatrics and Adolescent Medicine
    University Hospital of the RWTH Aachen Institute for Medical Microbiology
    Robert Koch Institute Department for Infectious Disease Epidemiology
  10. 1243
    OPEN-LABEL RANDOMISED CONTROLLED STUDY TO EVALUATE INDUCTION OF IMMUNE MEMORY FOLLOWING INFANT VACCINATION WITH GLYCO-CONJUGATE SEROGROUP C NEISSERIA MENINGITIDIS VACCINES
    A. Khatami
    J. McKenna
    A. Thompson
    D. Campbell
    E. Clutterbuck
    D. Pace
    M. Snape
    A. Pollard
    University of Oxford Oxford Vaccine Group
    University of Oxford Department of Paediatrics, Oxford Vaccine Group
    Malta Children's Vaccine Group